Veeva Announces Expanded Partnership with Roche

FierceBiotechInsulet debuts latest enhancements to popular Omnipod insulin delivery system

BioWorldNME Digest: Q1 2026

FierceBiotechChutes & Ladders—AstraZeneca adds FDA cell and gene veteran

BioWorldNew York University identifies new analogues of mannose-6-phosphate

BioWorldAvelos Therapeutics synthesizes new PARG inhibitors

BioWorldSimcere Zaiming Pharmaceutical discovers new MAPK inhibitors

LabiotechEight oncology deals in 2026 spotlight where industry leaders are betting big

Endpoints NewsFulcrum lays off majority of staff; Seres extends runway into 2027

PharmaVoiceGSK, Takeda and others notch key clinical wins in tough-to-treat diseases

FierceBiotechHow RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’

Endpoints NewsNovo vet Uli Stilz settles in at Flagship; Revolution Medicines welcomes commercial exec

BioPharma DivePharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?